Book Cover
Home  |   Healthcare   |  In Vivo Toxicology Market

In Vivo Toxicology Market Size, Share, Growth, and Industry Analysis, By Type (Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing), By Application (Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental and Reproductive Toxicity (DART), Other Toxicity Endpoints), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Detailed TOC of Global In Vivo Toxicology Industry Trends Analysis Report 2026, Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global In Vivo Toxicology Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 In Vivo Toxicology Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 In Vivo Toxicology Business Mode and Production Process
2.3.1 In Vivo Toxicology Business Mode Analysis
2.3.2 Production Process Analysis
2.4 In Vivo Toxicology Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of In Vivo Toxicology
2.4.2 Raw Material Cost of In Vivo Toxicology
2.4.3 Labor Cost of In Vivo Toxicology
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global In Vivo Toxicology Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global In Vivo Toxicology Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global In Vivo Toxicology Price by Manufacturer (2021-2026)
4.4 In Vivo Toxicology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of In Vivo Toxicology, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of In Vivo Toxicology, Product Offered and Application
4.7 In Vivo Toxicology Market Competitive Situation and Trends
4.7.1 In Vivo Toxicology Market Concentration Rate
4.7.2 Global Top 3 and Top 6 In Vivo Toxicology Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global In Vivo Toxicology Market Historical Development by Geographic Region (2021-2026)
5.1 Global In Vivo Toxicology Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global In Vivo Toxicology Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America In Vivo Toxicology Market Status by Country (2021-2026)
5.3.1 North America In Vivo Toxicology Sales Volume by Country (2021-2026)
5.3.2 North America In Vivo Toxicology Revenue by Country (2021-2026)
5.3.3 United States In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe In Vivo Toxicology Market Status by Country (2021-2026)
5.4.1 Europe In Vivo Toxicology Sales Volume by Country (2021-2026)
5.4.2 Europe In Vivo Toxicology Revenue by Country (2021-2026)
5.4.3 Germany In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific In Vivo Toxicology Market Status by Country (2021-2026)
5.5.1 Asia Pacific In Vivo Toxicology Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific In Vivo Toxicology Revenue by Country (2021-2026)
5.5.3 China In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America In Vivo Toxicology Market Status by Country (2021-2026)
5.6.1 Latin America In Vivo Toxicology Sales Volume by Country (2021-2026)
5.6.2 Latin America In Vivo Toxicology Revenue by Country (2021-2026)
5.6.3 Mexico In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa In Vivo Toxicology Market Status by Country (2021-2026)
5.7.1 Middle East and Africa In Vivo Toxicology Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa In Vivo Toxicology Revenue by Country (2021-2026)
5.7.3 GCC In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa In Vivo Toxicology Sales Volume, Revenue and Growth (2021-2026)

6 Global In Vivo Toxicology Market Historical Development by Product Type (2021-2026)
6.1 In Vivo Toxicology Definition by Type
6.2 Global In Vivo Toxicology Historical Sales Volume by Product Type (2021-2026)
6.3 Global In Vivo Toxicology Historical Revenue by Product Type (2021-2026)
6.4 Global In Vivo Toxicology Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global In Vivo Toxicology Historical Sales Volume, Revenue and Growth Rate of Chronic Toxicity Testing (2021-2026)
6.5.2 Global In Vivo Toxicology Historical Sales Volume, Revenue and Growth Rate of Sub-Chronic Toxicity Testing (2021-2026)
6.5.3 Global In Vivo Toxicology Historical Sales Volume, Revenue and Growth Rate of Sub-Acute Toxicity Testing (2021-2026)
6.5.4 Global In Vivo Toxicology Historical Sales Volume, Revenue and Growth Rate of Acute Toxicity Testing (2021-2026)

7 Global In Vivo Toxicology Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global In Vivo Toxicology Historical Sales Volume by End User (2021-2026)
7.3 Global In Vivo Toxicology Historical Revenue by End User (2021-2026)
7.4 Global In Vivo Toxicology Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global In Vivo Toxicology Historical Sales Volume, Revenue and Growth Rate of Immunotoxicity (2021-2026)
7.5.2 Global In Vivo Toxicology Historical Sales Volume, Revenue and Growth Rate of Systemic Toxicity (2021-2026)
7.5.3 Global In Vivo Toxicology Historical Sales Volume, Revenue and Growth Rate of Carcinogenicity (2021-2026)
7.5.4 Global In Vivo Toxicology Historical Sales Volume, Revenue and Growth Rate of Genotoxicity (2021-2026)
7.5.5 Global In Vivo Toxicology Historical Sales Volume, Revenue and Growth Rate of Developmental and Reproductive Toxicity (DART) (2021-2026)
7.5.6 Global In Vivo Toxicology Historical Sales Volume, Revenue and Growth Rate of Other Toxicity Endpoints (2021-2026)

8 Leading Companies Profiles
8.1 Data Sciences International
8.1.1 Data Sciences International Corporation Information
8.1.2 Data Sciences International - In Vivo Toxicology Product Portfolio and Specification
8.1.3 Data Sciences International Performance Analysis (2021-2026)
8.1.4 Data Sciences International Business and Markets Served
8.1.5 Data Sciences International Recent Developments
8.2 Taconic Biosciences
8.2.1 Taconic Biosciences Corporation Information
8.2.2 Taconic Biosciences - In Vivo Toxicology Product Portfolio and Specification
8.2.3 Taconic Biosciences Performance Analysis (2021-2026)
8.2.4 Taconic Biosciences Business and Markets Served
8.2.5 Taconic Biosciences Recent Developments
8.3 The Jackson Laboratory
8.3.1 The Jackson Laboratory Corporation Information
8.3.2 The Jackson Laboratory - In Vivo Toxicology Product Portfolio and Specification
8.3.3 The Jackson Laboratory Performance Analysis (2021-2026)
8.3.4 The Jackson Laboratory Business and Markets Served
8.3.5 The Jackson Laboratory Recent Developments
8.4 Thermo Fisher Scientific
8.4.1 Thermo Fisher Scientific Corporation Information
8.4.2 Thermo Fisher Scientific - In Vivo Toxicology Product Portfolio and Specification
8.4.3 Thermo Fisher Scientific Performance Analysis (2021-2026)
8.4.4 Thermo Fisher Scientific Business and Markets Served
8.4.5 Thermo Fisher Scientific Recent Developments
8.5 SRI International
8.5.1 SRI International Corporation Information
8.5.2 SRI International - In Vivo Toxicology Product Portfolio and Specification
8.5.3 SRI International Performance Analysis (2021-2026)
8.5.4 SRI International Business and Markets Served
8.5.5 SRI International Recent Developments
8.6 Wuxi Apptec
8.6.1 Wuxi Apptec Corporation Information
8.6.2 Wuxi Apptec - In Vivo Toxicology Product Portfolio and Specification
8.6.3 Wuxi Apptec Performance Analysis (2021-2026)
8.6.4 Wuxi Apptec Business and Markets Served
8.6.5 Wuxi Apptec Recent Developments
8.7 Danaher
8.7.1 Danaher Corporation Information
8.7.2 Danaher - In Vivo Toxicology Product Portfolio and Specification
8.7.3 Danaher Performance Analysis (2021-2026)
8.7.4 Danaher Business and Markets Served
8.7.5 Danaher Recent Developments
8.8 Eurofins Scientific
8.8.1 Eurofins Scientific Corporation Information
8.8.2 Eurofins Scientific - In Vivo Toxicology Product Portfolio and Specification
8.8.3 Eurofins Scientific Performance Analysis (2021-2026)
8.8.4 Eurofins Scientific Business and Markets Served
8.8.5 Eurofins Scientific Recent Developments
8.9 Labcorp
8.9.1 Labcorp Corporation Information
8.9.2 Labcorp - In Vivo Toxicology Product Portfolio and Specification
8.9.3 Labcorp Performance Analysis (2021-2026)
8.9.4 Labcorp Business and Markets Served
8.9.5 Labcorp Recent Developments
8.10 Perkinelmer
8.10.1 Perkinelmer Corporation Information
8.10.2 Perkinelmer - In Vivo Toxicology Product Portfolio and Specification
8.10.3 Perkinelmer Performance Analysis (2021-2026)
8.10.4 Perkinelmer Business and Markets Served
8.10.5 Perkinelmer Recent Developments
8.11 Charles River Laboratories
8.11.1 Charles River Laboratories Corporation Information
8.11.2 Charles River Laboratories - In Vivo Toxicology Product Portfolio and Specification
8.11.3 Charles River Laboratories Performance Analysis (2021-2026)
8.11.4 Charles River Laboratories Business and Markets Served
8.11.5 Charles River Laboratories Recent Developments
8.12 Envigo
8.12.1 Envigo Corporation Information
8.12.2 Envigo - In Vivo Toxicology Product Portfolio and Specification
8.12.3 Envigo Performance Analysis (2021-2026)
8.12.4 Envigo Business and Markets Served
8.12.5 Envigo Recent Developments

9 Global In Vivo Toxicology Market Forecast by Product Type and End User (2026-2035)
9.1 Global In Vivo Toxicology Market Forecast by Product Type (2026-2035)
9.1.1 Global In Vivo Toxicology Sales Volume, Revenue Forecast and Growth Rate of Chronic Toxicity Testing (2026-2035)
9.1.2 Global In Vivo Toxicology Sales Volume, Revenue Forecast and Growth Rate of Sub-Chronic Toxicity Testing (2026-2035)
9.1.3 Global In Vivo Toxicology Sales Volume, Revenue Forecast and Growth Rate of Sub-Acute Toxicity Testing (2026-2035)
9.1.4 Global In Vivo Toxicology Sales Volume, Revenue Forecast and Growth Rate of Acute Toxicity Testing (2026-2035)
9.2 Global In Vivo Toxicology Market Forecast by End User (2026-2035)
9.2.1 Global In Vivo Toxicology Sales Volume, Revenue Forecast and Growth Rate of Immunotoxicity (2026-2035)
9.2.2 Global In Vivo Toxicology Sales Volume, Revenue Forecast and Growth Rate of Systemic Toxicity (2026-2035)
9.2.3 Global In Vivo Toxicology Sales Volume, Revenue Forecast and Growth Rate of Carcinogenicity (2026-2035)
9.2.4 Global In Vivo Toxicology Sales Volume, Revenue Forecast and Growth Rate of Genotoxicity (2026-2035)
9.2.5 Global In Vivo Toxicology Sales Volume, Revenue Forecast and Growth Rate of Developmental and Reproductive Toxicity (DART) (2026-2035)
9.2.6 Global In Vivo Toxicology Sales Volume, Revenue Forecast and Growth Rate of Other Toxicity Endpoints (2026-2035)

10 Global In Vivo Toxicology Market Forecast by Geographic Region (2026-2035)
10.1 Global In Vivo Toxicology Sales Volume and Revenue Forecast by Geographic Region (2026-2035)
10.2 North America In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.1 United States In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.2 Canada In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3 Europe In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.1 Germany In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.2 France In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.3 United Kingdom In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.4 Spain In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.5 Russia In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.6 Poland In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4 Asia Pacific In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.1 China In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.2 Japan In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.3 South Korea In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.4 Southeast Asia In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.5 India In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.6 Australia In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5 Latin America In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.1 Mexico In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.2 Brazil In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6 Middle East and Africa In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.1 GCC In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.2 South Africa In Vivo Toxicology Sales Volume, Revenue Forecast and Growth (2026-2035)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer

Captcha refresh

Trusted & Certified

Our Clients